Media Advisory: Celebration of an Infrastructure Announcement in Antigonish
ANTIGONISH, NS, July 7, 2021 /CNW/ - Members of the media are invited to attend a celebration of an infrastructure funding announcement with Kody Blois, Member of Parliament for Kings?Hants, on behalf of the Honourable Catherine McKenna, Minister of Infrastructure and Communities; the Honourable Iain Rankin, Premier of Nova Scotia, and Her Worship Laurie Boucher, Mayor of the Town of Antigonish.
Date:
Thursday, July 8, 2021
Time:
2:00 p.m. ADT
Location:
Colin H. Chisholm Park
370 Main St.
Antigonish, Nova Scotia
To register, please contact Michael Noonan at [email protected]. Those attending will be required to wear a mask, sign in and provide their name and phone number for possible contact tracing.
Public health protocols are in effect: please stay home if you are experiencing any of the symptoms listed here: https://novascotia.ca/coronavirus/when-to-seek-help/#symptoms, practise good hand washing and other hygiene steps, as well as physical distancing.
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...
